Global Oncology Based Preclinical CRO Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Oncology Based Preclinical CRO market size will reach 587.71 Million USD in 2025 and is projected to reach 1,295.99 Million USD by 2032, with a CAGR of 11.96% (2025-2032). Notably, the China Oncology Based Preclinical CRO market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An Oncology Based Preclinical CRO (Contract Research Organization) is a specialized service provider that conducts preclinical research and development activities focused on cancer treatments and therapies. These organizations offer a range of services to support oncology drug discovery and development, including in vitro (cell-based) and in vivo (animal-based) studies. The preclinical CROs work closely with pharmaceutical companies, biotechnology firms, and academic institutions to help evaluate the safety, efficacy, and mechanism of action of potential cancer therapies. They employ various techniques, such as cell culture, animal modeling, tumor xenograft studies, pharmacokinetics, and toxicology assessments, to assess the potential of new anti-cancer compounds. The data generated by preclinical CROs is crucial for determining whether a particular drug candidate should progress to clinical trials and provides valuable insights into the drug’s behavior, dosage, and potential adverse effects. By conducting specialized oncology-focused preclinical studies, these CROs play a pivotal role in advancing cancer research and aiding the development of promising therapies to improve patient outcomes.
The major global suppliers of Oncology Based Preclinical CRO include Crown Bioscience, Charles River, ICON, Eurofins Scientific, EVOTEC, Covance, Taconic Biosciences, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Living Tumor Laboratory, Xentech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncology Based Preclinical CRO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oncology Based Preclinical CRO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oncology Based Preclinical CRO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncology Based Preclinical CRO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oncology Based Preclinical CRO Include:
Crown Bioscience
Charles River
ICON
Eurofins Scientific
EVOTEC
Covance
Taconic Biosciences
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Living Tumor Laboratory
Xentech
Oncology Based Preclinical CRO Product Segment Include:
Blood Cancer
Solid Tumors
Others
Oncology Based Preclinical CRO Product Application Include:
In Vitro
In Vivo
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oncology Based Preclinical CRO Industry PESTEL Analysis
Chapter 3: Global Oncology Based Preclinical CRO Industry Porter's Five Forces Analysis
Chapter 4: Global Oncology Based Preclinical CRO Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oncology Based Preclinical CRO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oncology Based Preclinical CRO Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oncology Based Preclinical CRO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Oncology Based Preclinical CRO market size will reach 587.71 Million USD in 2025 and is projected to reach 1,295.99 Million USD by 2032, with a CAGR of 11.96% (2025-2032). Notably, the China Oncology Based Preclinical CRO market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An Oncology Based Preclinical CRO (Contract Research Organization) is a specialized service provider that conducts preclinical research and development activities focused on cancer treatments and therapies. These organizations offer a range of services to support oncology drug discovery and development, including in vitro (cell-based) and in vivo (animal-based) studies. The preclinical CROs work closely with pharmaceutical companies, biotechnology firms, and academic institutions to help evaluate the safety, efficacy, and mechanism of action of potential cancer therapies. They employ various techniques, such as cell culture, animal modeling, tumor xenograft studies, pharmacokinetics, and toxicology assessments, to assess the potential of new anti-cancer compounds. The data generated by preclinical CROs is crucial for determining whether a particular drug candidate should progress to clinical trials and provides valuable insights into the drug’s behavior, dosage, and potential adverse effects. By conducting specialized oncology-focused preclinical studies, these CROs play a pivotal role in advancing cancer research and aiding the development of promising therapies to improve patient outcomes.
The major global suppliers of Oncology Based Preclinical CRO include Crown Bioscience, Charles River, ICON, Eurofins Scientific, EVOTEC, Covance, Taconic Biosciences, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Living Tumor Laboratory, Xentech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncology Based Preclinical CRO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oncology Based Preclinical CRO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oncology Based Preclinical CRO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncology Based Preclinical CRO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oncology Based Preclinical CRO Include:
Crown Bioscience
Charles River
ICON
Eurofins Scientific
EVOTEC
Covance
Taconic Biosciences
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Living Tumor Laboratory
Xentech
Oncology Based Preclinical CRO Product Segment Include:
Blood Cancer
Solid Tumors
Others
Oncology Based Preclinical CRO Product Application Include:
In Vitro
In Vivo
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oncology Based Preclinical CRO Industry PESTEL Analysis
Chapter 3: Global Oncology Based Preclinical CRO Industry Porter's Five Forces Analysis
Chapter 4: Global Oncology Based Preclinical CRO Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oncology Based Preclinical CRO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oncology Based Preclinical CRO Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oncology Based Preclinical CRO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oncology Based Preclinical CRO Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oncology Based Preclinical CRO Product by Type
- 1.2.1 Blood Cancer
- 1.2.2 Solid Tumors
- 1.2.3 Others
- 1.3 Oncology Based Preclinical CRO Product by Application
- 1.3.1 In Vitro
- 1.3.2 In Vivo
- 1.4 Global Oncology Based Preclinical CRO Market Size Analysis (2020-2032)
- 1.5 Oncology Based Preclinical CRO Market Development Status and Trends
- 1.5.1 Oncology Based Preclinical CRO Industry Development Status Analysis
- 1.5.2 Oncology Based Preclinical CRO Industry Development Trends Analysis
- 2 Oncology Based Preclinical CRO Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oncology Based Preclinical CRO Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oncology Based Preclinical CRO Market Analysis by Country
- 4.1 Global Oncology Based Preclinical CRO Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oncology Based Preclinical CRO Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Oncology Based Preclinical CRO Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.5 China Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.6 France Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.14 India Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Oncology Based Preclinical CRO Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Oncology Based Preclinical CRO Market Revenue by Key Suppliers (2021-2025)
- 5.2 Oncology Based Preclinical CRO Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oncology Based Preclinical CRO Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oncology Based Preclinical CRO Market Analysis by Type
- 6.1 Global Oncology Based Preclinical CRO Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Oncology Based Preclinical CRO Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Crown Bioscience
- 7.1.1 Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Crown Bioscience Oncology Based Preclinical CRO Product Portfolio
- 7.1.3 Crown Bioscience Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Charles River
- 7.2.1 Charles River Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Charles River Oncology Based Preclinical CRO Product Portfolio
- 7.2.3 Charles River Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 ICON
- 7.3.1 ICON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 ICON Oncology Based Preclinical CRO Product Portfolio
- 7.3.3 ICON Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Eurofins Scientific
- 7.4.1 Eurofins Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Eurofins Scientific Oncology Based Preclinical CRO Product Portfolio
- 7.4.3 Eurofins Scientific Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 EVOTEC
- 7.5.1 EVOTEC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 EVOTEC Oncology Based Preclinical CRO Product Portfolio
- 7.5.3 EVOTEC Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Covance
- 7.6.1 Covance Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Covance Oncology Based Preclinical CRO Product Portfolio
- 7.6.3 Covance Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Taconic Biosciences
- 7.7.1 Taconic Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Taconic Biosciences Oncology Based Preclinical CRO Product Portfolio
- 7.7.3 Taconic Biosciences Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 The Jackson Laboratory
- 7.8.1 The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 The Jackson Laboratory Oncology Based Preclinical CRO Product Portfolio
- 7.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 MI Bioresearch
- 7.9.1 MI Bioresearch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 MI Bioresearch Oncology Based Preclinical CRO Product Portfolio
- 7.9.3 MI Bioresearch Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Champion Oncology
- 7.10.1 Champion Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Champion Oncology Oncology Based Preclinical CRO Product Portfolio
- 7.10.3 Champion Oncology Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Wuxi AppTec.
- 7.11.1 Wuxi AppTec. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Wuxi AppTec. Oncology Based Preclinical CRO Product Portfolio
- 7.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Living Tumor Laboratory
- 7.12.1 Living Tumor Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Living Tumor Laboratory Oncology Based Preclinical CRO Product Portfolio
- 7.12.3 Living Tumor Laboratory Oncology Based Preclinical CRO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Xentech
- 7.13.1 Xentech Basic C
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
